Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
38.78
-1.44 (-3.58%)
Dec 5, 2025, 4:00 PM EST - Market closed
Immunocore Holdings Stock Forecast
Stock Price Forecast
According to 8 professional analysts, the 12-month price target for Immunocore Holdings stock ranges from a low of $33 to a high of $100. The average analyst price target of $67 forecasts a 72.77% increase in the stock price over the next year.
Price Target: $67.00 (+72.77%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Immunocore Holdings stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 4 | 4 | 2 | 3 | 3 | 3 |
| Hold | 3 | 3 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 0 | 0 | 0 |
| Total | 10 | 10 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $34 → $36 | Hold | Maintains | $34 → $36 | -7.17% | Nov 10, 2025 |
| Wells Fargo | Wells Fargo | Buy Initiates $60 | Buy | Initiates | $60 | +54.72% | Oct 31, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +157.86% | Oct 22, 2025 |
| Guggenheim | Guggenheim | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 18, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $100 | Strong Buy | Reiterates | $100 | +157.86% | Jun 2, 2025 |
Financial Forecast
Revenue This Year
410.44M
from 310.20M
Increased by 32.31%
Revenue Next Year
453.53M
from 410.44M
Increased by 10.50%
EPS This Year
-0.41
from -1.02
EPS Next Year
-1.22
from -0.41
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 428.9M | 496.4M | ||||
| Avg | 410.4M | 453.5M | ||||
| Low | 390.3M | 409.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 38.3% | 20.9% | ||||
| Avg | 32.3% | 10.5% | ||||
| Low | 25.8% | -0.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -0.12 | -0.23 | ||||
| Avg | -0.41 | -1.22 | ||||
| Low | -1.38 | -2.82 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.